Crystals Crypto Pharmaceuticals Private Limited
About Crystals Crypto Pharmaceuticals Private Limited
Data last updated:
Crystals Crypto Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC263323.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hemant Kalyan Gulavani and Amol Parasu Kamble.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/604 Star Enclave Pushpa Park Residency Near Padmavati Bolinj Vasai Thane – 401303, Maharashtra, India – 401303.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Crystals Crypto Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB/604 Star Enclave Pushpa Park Residency Near Padmavati Bolinj Vasai Thane – 401303, Maharashtra, India – 401303
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Crystals Crypto Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Crystals Crypto Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crystals Crypto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Crystals Crypto Pharmaceuticals Private Limited
Crystals Crypto Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemant Kalyan Gulavani | Director | 07 Apr 2015 | 11 Years 6 Months | Current |
| Amol Parasu Kamble | Director | 07 Apr 2015 | 11 Years 6 Months | Current |
Auditor
Crystals Crypto Pharmaceuticals Private Limited is audited by S R BAKARE & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R BAKARE & CO | FY 2018 | 140792W |
Shareholding
The shareholding of Crystals Crypto Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Crystals Crypto Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Crystals Crypto Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crystals Crypto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Crystals Crypto Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Crystals Crypto Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Amol Parasu Kamble was appointed as Director on 07 Apr 2015.
Frequently asked questions
Crystals Crypto Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 April 2015 (11+ years old) and is registered under CIN U74999MH2015PTC263323.
Crystals Crypto Pharmaceuticals has 2 current directors:
- Hemant Kalyan Gulavani - Director
- Amol Parasu Kamble - Director
The latest financial statements of Crystals Crypto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Crystals Crypto Pharmaceuticals is U74999MH2015PTC263323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crystals Crypto Pharmaceuticals was incorporated on 07 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Amol Parasu Kamble was appointed as Director on 07 Apr 2015. Hemant Kalyan Gulavani was appointed as Director on 07 Apr 2015.
The registered office of Crystals Crypto Pharmaceuticals is at B604 Star Enclave Pushpa Park Residency Near Padmavati Bolinj Vasai Thane – 401303, Maharashtra, India – 401303.
Crystals Crypto Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Crystals Crypto Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Crystals Crypto Pharmaceuticals can be reached at its registered office: B604 Star Enclave Pushpa Park Residency Near Padmavati Bolinj Vasai Thane – 401303, Maharashtra, India – 401303.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
